Ozempic vs Wegovy: What's the Real Difference?

Ozempic and Wegovy both contain semaglutide — the same GLP-1 receptor agonist — but they are FDA-approved for different conditions and come in different dose ranges.

Ozempic is approved for type 2 diabetes management. Its maximum approved dose is 2mg weekly. Many physicians prescribe it off-label for weight loss, but insurance coverage specifically for obesity is rare under this indication.

Wegovy is approved specifically for chronic weight management in adults with a BMI ≥30 or ≥27 with a weight-related condition. It goes up to 2.4mg weekly — slightly higher than Ozempic's ceiling — and insurance is more likely to cover it for weight loss.

What actually matters for weight loss: The clinical trials that established semaglutide's 15–17% average body weight reduction used the 2.4mg Wegovy dose. At the Ozempic ceiling of 2mg, results are slightly lower on average.

Compounded semaglutide from telehealth providers like Measured operates outside the brand-name distinction entirely. Compounded versions are not Ozempic or Wegovy — they are copies produced at FDA-registered pharmacies. This is currently the most affordable path to semaglutide for most self-pay patients.

The bottom line: If you have insurance that covers Wegovy, use it. If you're self-pay, compounded semaglutide from a reputable telehealth provider is functionally equivalent and substantially cheaper.